A good year for European rheumatology

Por Kvien, T K
Publicado em 2007

Treating rheumatoid arthritis

Por Emery, Paul, Kvien, Tore K
Publicado em 2007

Comparisons of 7- to 78-joint ultrasonography scores: all different joint combinations show equal response to adalimumab treatment in patients with rheumatoid arthritis

Por Hammer, Hilde Berner, Kvien, Tore K
Publicado em 2011

Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis

Por Uhlig, T., Kvien, T. K., Jensen, J. L., Axell, T.
Publicado em 1999

Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss

Por Hoff, Mari, Haugeberg, Glenn, Kvien, Tore K
Publicado em 2007

Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group

Por Halpern, M T, Cifaldi, M A, Kvien, T K
Publicado em 2008

EULAR expects further development in 2006

Por Kvien, T K, van de Putte, L B A
Publicado em 2006

Controlling the obesity epidemic is important for maintaining musculoskeletal health

Por Woolf, A D, Breedveld, F C, Kvien, T K
Publicado em 2006

Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean?

Por Kvien, Tore K, Heiberg, Turid, Hagen, Kåre B
Publicado em 2007

Introducing RMD Open

Por Cutolo, Maurizio, Burmester, Gerd R, Kvien, Tore K
Publicado no RMD Open (2015)

Patient participation as an integral part of patient-reported outcomes development ensures the representation of the patient voice: a case study from the field of rheumatology

Por de Wit, M P T, Kvien, T K, Gossec, L
Publicado no RMD Open (2015)

Ultrasound of the hand is sufficient to detect subclinical inflammation in rheumatoid arthritis remission: a post hoc longitudinal study

Por Hammer, Hilde Berner, Kvien, Tore K., Terslev, Lene
Publicado no Arthritis Res Ther (2017)

Intermetatarsal bursitis is frequent in patients with established rheumatoid arthritis and is associated with anti-cyclic citrullinated peptide and rheumatoid factor

Por Hammer, Hilde Berner, Kvien, Tore K, Terslev, L
Publicado no RMD Open (2019)

Development and preliminary validation of the pancreatic cancer disease impact score

Por Heiberg, Turid, Nordby, Tom, Kvien, Tore K, Buanes, Trond
Publicado em 2013

Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis.

Por Dobloug, J H, Førre, O, Kvien, T K, Egeland, T, Degré, M
Publicado em 1982

Bone mineral density in patients with hand osteoarthritis compared to population controls and patients with rheumatoid arthritis

Por Haugen, I K, Slatkowsky‐Christensen, B, Ørstavik, R, Kvien, T K
Publicado em 2007

Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study

Por Hoff, M, Kvien, T K, Kälvesten, J, Elden, A, Haugeberg, G
Publicado em 2008

Pain and psychological health status over a 10‐year period in patients with recent onset rheumatoid arthritis

Por Ødegård, Sigrid, Finset, Arnstein, Mowinckel, Petter, Kvien, Tore K., Uhlig, Till
Publicado em 2007

Perception of Improvement in Patients With Rheumatoid Arthritis Varies With Disease Activity Levels at Baseline

Por ALETAHA, D., FUNOVITS, J., WARD, M. M., SMOLEN, J. S., KVIEN, T. K.
Publicado em 2009

The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with...

Por Hammer, Hilde Berner, Fagerhol, Magne K, Wien, Tale Norbye, Kvien, Tore K
Publicado em 2011